← All trials
NCT00245518
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 30, 2005
- Primary completion
- Sep 30, 2008
- Completion date
- Sep 30, 2008
- First posted
- Oct 28, 2005
- Last posted
- Oct 13, 2017
- Enrollment
- 39
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Johns Hopkins UniversityLead sponsor
- Johns Hopkins UniversityOverall official - principal investigator
- National Cancer Institute (NCI)Collaborator
- Johns Hopkins UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.